(Q37378896)

English

Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Wo

scientific article published on 27 January 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

circulatory system

1 reference

based on heuristic

inferred from title

Wiktor Kuliczkowski

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jacek Golański

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Dariusz Sitkiewicz

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

11

object named as

Marian Zembala

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Krzysztof Jerzy Filipiak

5

object named as

Krzysztof Filipiak

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Grzegorz Opolski

12

object named as

Grzegorz Opolski

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

2

object named as

Adam Witkowski

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

3

object named as

Lech Polonski

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jerzy Pręgowski

9

object named as

Jerzy Pregowski

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Raffaele De Caterina

16

object named as

Raffaele De Caterina

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

4

object named as

Cezary Watala

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Jacek Gorski

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Kurt Huber

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Harald Arnesen

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Steen D Kristensen

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

27 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

426-435

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19174428%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Ticlopidine and clopidogrel

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

One-year cardiovascular event rates in outpatients with atherothrombosis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Resistance to antiplatelet drugs: current status and future research

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Variability in platelet responsiveness to clopidogrel among 544 individuals.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Drug metabolism and variability among patients in drug response

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Aspirin and clopidogrel resistance: consideration and management

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Measuring antiplatelet drug effects in the laboratory

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Screening for aspirin resistance in stable coronary artery patients by three different tests

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Platelet function tests and flow cytometry to monitor antiplatelet therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

More on aspirin resistance: position paper of the Working Group on Aspirin Resistance. Proposal for a Laboratory Test Guiding Algorithm

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

The genetics of aspirin resistance

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Cyclooxygenase-1 haplotype modulates platelet response to aspirin

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

ADP Receptors-Targets for Developing Antithrombotic Agents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Aspirin resistance

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

The "clopidogrel resistance" trap

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

High-dose aspirin in addition to daily low-dose aspirin decreases platelet activation in patients before and after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol design

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Cilostazol could ameliorate platelet responsiveness to clopidogrel in patients undergoing primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Baseline platelet reactivity in acute myocardial infarction treated with primary angioplasty--influence on myocardial reperfusion, left ventricular performance, and clinical events.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Clopidogrel resistance: role of body mass and concomitant medications

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Frequency of aspirin resistance in a community hospital

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Long-term adherence with cardiovascular drug regimens

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN562

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37378896&oldid=2086517107"